Natrix Separations Inc., a Canadian maker of membrane-based disposable chromatography products, has raised C$19 million in Series B funding. D.E. Shaw Venture Capital led the round, and was joined by the Canadian Medical Discoveries Fund (managed by JovInvestment Management) and BDC Venture Capital.
PRESS RELEASE
Natrix Separations Inc., a privately held company that develops and manufactures high performance, membrane-based disposable chromatography products, announced today that it has closed a Series B financing totaling $19 Million. The round was led by D.E. Shaw Venture Capital of